BRYVEO

Serial Number 77888710
606

Registration Progress

Application Filed
Dec 8, 2009
Under Examination
Jun 1, 2010
Approved for Publication
Apr 6, 2010
Published for Opposition
Apr 6, 2010
Registered

Trademark Image

BRYVEO

Basic Information

Serial Number
77888710
Filing Date
December 8, 2009
Published for Opposition
April 6, 2010
Abandonment Date
July 1, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 1, 2013
Classes
005

Rights Holder

Agouron Pharmaceuticals, Inc.

03
Address
10646 Science Center Drive
San Diego, CA 92121

Ownership History

Agouron Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Agouron Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Heather McDonald

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description
Jul 1, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jul 1, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Nov 24, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 23, 2012 EX5G S SOU EXTENSION 5 GRANTED
Nov 21, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 21, 2012 EXT5 S SOU EXTENSION 5 FILED
Jun 7, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 6, 2012 EX4G S SOU EXTENSION 4 GRANTED
May 8, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
May 8, 2012 EXT4 S SOU EXTENSION 4 FILED
Oct 15, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2011 EX3G S SOU EXTENSION 3 GRANTED
Oct 6, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 6, 2011 EXT3 S SOU EXTENSION 3 FILED
Apr 28, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2011 EX2G S SOU EXTENSION 2 GRANTED
Apr 25, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 25, 2011 EXT2 S SOU EXTENSION 2 FILED
Nov 27, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 26, 2010 EX1G S SOU EXTENSION 1 GRANTED
Nov 14, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 14, 2010 EXT1 S SOU EXTENSION 1 FILED
Jun 1, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 6, 2010 PUBO A PUBLISHED FOR OPPOSITION
Apr 6, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 2, 2010 ALIE A ASSIGNED TO LIE
Mar 2, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 3, 2010 DOCK D ASSIGNED TO EXAMINER
Feb 3, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2009 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, and pain; pharmaceutical preparations, namely, antifungal preparations, smoking cessation preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...